| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0092-8674(84)90306-4 |
| P698 | PubMed publication ID | 6327047 |
| P50 | author | Lynn M. Corcoran | Q90292224 |
| Jerry Adams | Q6183179 | ||
| Suzanne Cory | Q1231087 | ||
| P2093 | author name string | Dunn AR | |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 113-122 | |
| P577 | publication date | 1984-05-01 | |
| P1433 | published in | Cell | Q655814 |
| P1476 | title | Murine T lymphomas in which the cellular myc oncogene has been activated by retroviral insertion | |
| P478 | volume | 37 |
| Q36781332 | 6;7 chromosomal translocation in spontaneously arising rat immunocytomas: evidence for c-myc breakpoint clustering and correlation between isotypic expression and the c-myc target |
| Q36894915 | A 3' end fragment encompassing the transcriptional enhancers of nondefective Friend virus confers erythroleukemogenicity on Moloney leukemia virus |
| Q36864589 | A mouse c-myc retrovirus transforms established fibroblast lines in vitro and induces monocyte-macrophage tumors in vivo |
| Q35861712 | A multistep process of leukemogenesis in Moloney murine leukemia virus-infected mice that is modulated by retroviral pseudotyping and interference. |
| Q41826773 | A negative transcriptional control element located upstream of the murine c-myc gene |
| Q36686850 | A protein-binding site with dyad symmetry in the long terminal repeat of the MCF13 murine leukemia virus that contributes to transcriptional activity in T lymphocytes. |
| Q36901229 | AKXD recombinant inbred strains: models for studying the molecular genetic basis of murine lymphomas |
| Q36890641 | Accurate and efficient transcription of human c-myc genes injected into Xenopus laevis oocytes |
| Q44098997 | Activation of Lyt-2 associated with distant upstream insertion of an SL3-3 provirus |
| Q39672951 | Activation of cellular oncogenes in human and mouse leukemia-lymphomas: spontaneous and induced oncogene expression in murine B lymphocytic neoplasms |
| Q37690084 | Activation of the c-myc oncogene by the immunoglobulin heavy-chain gene enhancer after multiple switch region-mediated chromosome rearrangements in a murine plasmacytoma |
| Q69872084 | Acute myelogenous leukaemia with c-myc amplification and double minute chromosomes |
| Q45784407 | Akv murine leukemia virus enhances bone tumorigenesis in hMT-c-fos-LTR transgenic mice |
| Q45207034 | Akv murine leukemia virus enhances lymphomagenesis in myc-kappa transgenic and in wild-type mice |
| Q36800277 | Alignment of U3 region sequences of mammalian type C viruses: identification of highly conserved motifs and implications for enhancer design |
| Q37747489 | Analysis of wild-type and mutant SL3-3 murine leukemia virus insertions in the c-myc promoter during lymphomagenesis reveals target site hot spots, virus-dependent patterns, and frequent error-prone gap repair |
| Q57981004 | Animal hepadnaviruses and their host species: Models for human hepatocarcinogenesis |
| Q69610486 | Assignment of the human homologue of Pim-1, a mouse gene implicated in leukemogenesis, to the pter-q12 region of chromosome 6 |
| Q36903997 | At least four viral genes contribute to the leukemogenicity of murine retrovirus MCF 247 in AKR mice |
| Q36835276 | At least two nuclear proteins bind specifically to the Rous sarcoma virus long terminal repeat enhancer |
| Q36952471 | Augmented expression of normal c-myc is sufficient for cotransformation of rat embryo cells with a mutant ras gene |
| Q33880155 | Autocrine growth and progression of murine X-ray-induced T cell lymphomas. |
| Q39582379 | B-Cell lymphoma induction by akv murine leukemia viruses harboring one or both copies of the tandem repeat in the U3 enhancer. |
| Q36653547 | BCR-ABL and v-abl oncogenes induce distinct patterns of thymic lymphoma involving different lymphocyte subsets |
| Q38337312 | Binding of SL3-3 enhancer factor 1 transcriptional activators to viral and chromosomal enhancer sequences |
| Q53520318 | C-myc expression and transformed phenotypes in hybrid clones between mouse plasmacytoma S194 cells and normal spleen cells or fibroblasts |
| Q89556785 | Cancer LncRNA Census reveals evidence for deep functional conservation of long noncoding RNAs in tumorigenesis |
| Q34962407 | Cancer gene discovery in mouse and man. |
| Q24615673 | Characterization and chromosome assignment of the human homolog of int-2, a potential proto-oncogene |
| Q36350428 | Characterization of gP85gag as an antigen recognized by Moloney leukemia virus-specific cytolytic T cell clones that function in vivo |
| Q35832136 | Characterization of nuclear protein binding to a site in the long terminal repeat of a murine leukemia virus: comparison with the NFAT complex |
| Q35874552 | Characterization of pal-1, a common proviral insertion site in murine leukemia virus-induced lymphomas of c-myc and Pim-1 transgenic mice |
| Q36918860 | Characterization of somatically acquired ecotropic and mink cell focus-forming viruses in lymphomas of AKXD recombinant inbred mice. |
| Q39726566 | Chemically induced aneuploidy in mammalian cells: mechanisms and biological significance in cancer |
| Q33932005 | Chromatin structure of the murine c-myc locus: implications for the regulation of normal and chromosomally translocated genes. |
| Q33931026 | Chromosome translocation activates heterogeneously initiated, bipolar transcription of a mouse c-myc gene |
| Q33931387 | Chromosome translocations clustered 5' of the murine c-myc gene qualitatively affect promoter usage: implications for the site of normal c-myc regulation |
| Q36857589 | Common proviral integration region on mouse chromosome 7 in lymphomas and myelogenous leukemias induced by Friend murine leukemia virus |
| Q36875968 | Comparative molecular genetic analysis of lymphomas from six inbred mouse strains |
| Q37675766 | Comparison of chemically induced and spontaneous murine thymic lymphomas in RF and AKR mice: differential expression of c-myc and c-myb |
| Q36851262 | Concerted DNA rearrangements in Moloney murine leukemia virus-induced thymomas: a potential synergistic relationship in oncogenesis |
| Q45836874 | Concerted activation of two potential proto-oncogenes in carcinomas induced by mouse mammary tumour virus |
| Q51211851 | Constitutive c-myc oncogene expression blocks mouse erythroleukaemia cell differentiation but not commitment. |
| Q36686893 | Contributions to transcriptional activity and to viral leukemogenicity made by sequences within and downstream of the MCF13 murine leukemia virus enhancer |
| Q36839982 | Definition of regions in human c-myc that are involved in transformation and nuclear localization |
| Q36798128 | Deletion of a GC-rich region flanking the enhancer element within the long terminal repeat sequences alters the disease specificity of Moloney murine leukemia virus |
| Q36900352 | Deregulation of the c-myc oncogene in virus-induced thymic lymphomas of AKR/J mice |
| Q35789006 | Developmentally regulated alternative splicing in the Xenopus laevis c-Myc gene creates an intron-1 containing c-Myc RNA present only in post-midblastula embryos |
| Q36904085 | Different genes control the susceptibility of mice to Moloney or Abelson murine leukemia viruses |
| Q37730320 | Differential cell killing by lymphomagenic murine leukemia viruses occurs independently of p53 activation and mitochondrial damage |
| Q36920022 | Differential promoter utilization by the c-myc gene in mitogen- and interleukin-2-stimulated human lymphocytes |
| Q36827379 | Distinct helper virus requirements for Abelson murine leukemia virus-induced pre-B- and T-cell lymphomas |
| Q35086103 | Distribution of lentiviral vector integration sites in mice following therapeutic gene transfer to treat β-thalassemia |
| Q36886626 | Dsi-1, a region with frequent proviral insertions in Moloney murine leukemia virus-induced rat thymomas |
| Q34757976 | Duplication of U3 sequences in the long terminal repeat of mink cell focus-inducing viruses generates redundancies of transcription factor binding sites important for the induction of thymomas |
| Q36903499 | Early clonality and high-frequency proviral integration into the c-myc locus in AKR leukemias |
| Q40125980 | Ecotropic and mink cell focus-forming murine leukemia viruses integrate in mouse T, B, and non-T/non-B cell lymphoma DNA. |
| Q36353506 | Elevated myc expression and c-myc amplification in spontaneously occurring B lymphoid cell lines |
| Q35594513 | Enhanced c-Ki-ras expression associated with Friend virus integration in a bone marrow-derived mouse cell line |
| Q33931128 | Enhancer activity correlates with the oncogenic potential of avian retroviruses |
| Q40109552 | Enhancer functions in U3 of Akv virus: a role for cooperativity of a tandem repeat unit and its flanking DNA sequences |
| Q36902849 | Envelope gene and long terminal repeat determine the different biological properties of Rauscher, Friend, and Moloney mink cell focus-inducing viruses |
| Q33933218 | Evi-2, a common integration site involved in murine myeloid leukemogenesis |
| Q48368270 | Expression of a new tyrosine protein kinase is stimulated by retrovirus promoter insertion |
| Q35575572 | Expression of c-myc proto-oncogene in normal human lymphocytes. Regulation by transcriptional and posttranscriptional mechanisms |
| Q36706072 | Expression of the woodchuck N-myc2 retroposon in brain and in liver tumors is driven by a cryptic N-myc promoter |
| Q36918435 | Features of the chicken c-myc gene that influence the structure of c-myc RNA in normal cells and bursal lymphomas |
| Q36468987 | Feline Leukaemia Virus: Generation of Pathogenic and Oncogenic Variants |
| Q35233647 | Feline leukemia virus: pathogenesis of neoplastic disease |
| Q36881208 | Fim-1, Fim-2/c-fms, and Fim-3, three common integration sites of Friend murine leukemia virus in myeloblastic leukemias, map to mouse chromosomes 13, 18, and 3, respectively |
| Q37599222 | Frequent amplification of c-myc in ground squirrel liver tumors associated with past or ongoing infection with a hepadnavirus |
| Q54613997 | Further implications of the territorial effects of genes: chromosomal translocation and oncogene activation. |
| Q36883505 | Generation and characterization of a recombinant Moloney murine leukemia virus containing the v-myc oncogene of avian MC29 virus: in vitro transformation and in vivo pathogenesis |
| Q38705279 | Genetic basis of disease specificity of nondefective Friend murine leukemia virus |
| Q36888090 | Genetic mapping of a cellular DNA region involved in induction of thymic lymphomas (Mlvi-1) to mouse chromosome 15 |
| Q44540488 | Genetic mapping of the gene coding for the integrin beta 7 subunit to the distal part of mouse chromosome 15 |
| Q35025373 | Genetic profile of insertion mutations in mouse leukemias and lymphomas |
| Q33307636 | Genome-wide changes in expression profile of murine endogenous retroviruses (MuERVs) in distant organs after burn injury |
| Q44482357 | Hepatitis B virus-related insertional mutagenesis occurs frequently in human liver cancers and recurrently targets human telomerase gene. |
| Q35232789 | Hepatitis B viruses and hepatocellular carcinoma |
| Q36900874 | High-frequency transduction of c-erbB in avian leukosis virus-induced erythroblastosis |
| Q24559244 | Identification and mapping of a common proviral integration site Fli-1 in erythroleukemia cells induced by Friend murine leukemia virus |
| Q36780634 | Identification of a common ecotropic viral integration site, Evi-1, in the DNA of AKXD murine myeloid tumors |
| Q36881255 | Identification of a common helper provirus integration site in Abelson murine leukemia virus-induced lymphoma DNA. |
| Q24647823 | Identification of a common viral integration region in Cas-Br-E murine leukemia virus-induced non-T-, non-B-cell lymphomas |
| Q36426627 | Identification of a new common provirus integration site in gross passage A murine leukemia virus-induced mouse thymoma DNA. |
| Q33879376 | Identification of a provirally activated c-Ha-ras oncogene in an avian nephroblastoma via a novel procedure: cDNA cloning of a chimaeric viral-host transcript |
| Q36633701 | Identification of a region of a murine leukemia virus long terminal repeat with novel transcriptional regulatory activities |
| Q41335376 | Identification of genes involved in growth autonomy of hematopoietic cells by analysis of factor-independent mutants |
| Q28216596 | Identification of oncogenes collaborating with p27Kip1 loss by insertional mutagenesis and high-throughput insertion site analysis |
| Q36964728 | In vitro transfection of fresh thymocytes and T cells shows subset-specific expression of viral promoters |
| Q33919331 | In vivo transformation of factor-dependent hemopoietic cells: role of intracisternal A-particle transposition for growth factor gene activation |
| Q36834908 | Induction of clonal monocyte-macrophage tumors in vivo by a mouse c-myc retrovirus: rearrangement of the CSF-1 gene as a secondary transforming event |
| Q36792180 | Induction of nephroblastoma by myeloblastosis-associated virus type 1: state of proviral DNAs in tumor cells |
| Q36820570 | Influence of murine leukemia proviral integrations on development of N-methyl-N-nitrosourea-induced thymic lymphomas in AKR mice |
| Q36902342 | Insertional activation of c-myc by reticuloendotheliosis virus in chicken B lymphoma: nonrandom distribution and orientation of the proviruses |
| Q36697386 | Insertional mutagenesis of flvi-2 in tumors induced by infection with LC-FeLV, a myc-containing strain of feline leukemia virus |
| Q37365254 | Insertional mutagenesis: neoplasia arising from retroviral integration. |
| Q35148357 | Insertional mutations in mammals and mammalian cells |
| Q44828202 | Integration of hepatitis virus DNA near c-myc in woodchuck hepatocellular carcinoma |
| Q33880694 | Intragenic pausing and anti-sense transcription within the murine c-myc locus |
| Q41588412 | Involvement of c-myc in MuLV-induced T cell lymphomas in mice: frequency and mechanisms of activation |
| Q38339444 | Involvement of nuclear factor I-binding sites in control of Akv virus gene expression |
| Q36784457 | Lack of ecotropic virus involvement in induction of lymphomas in DBA/2J mice by 7,12-dimethylbenz(a)anthracene |
| Q35598151 | Large scaled analysis of hepatitis B virus (HBV) DNA integration in HBV related hepatocellular carcinomas |
| Q37223750 | Lessons Learned from Mouse Mammary Tumor Virus in Animal Models |
| Q34837257 | Lipopolysaccharide stress induces cell-type specific production of murine leukemia virus type-endogenous retroviral virions in primary lymphoid cells |
| Q39868453 | Long terminal repeat enhancer core sequences in proviruses adjacent to c-myc in T-cell lymphomas induced by a murine retrovirus. |
| Q37660806 | Long-distance activation of the Myc protooncogene by provirus insertion in Mlvi-1 or Mlvi-4 in rat T-cell lymphomas |
| Q36652861 | Long-range mapping of Mis-2, a common provirus integration site identified in murine leukemia virus-induced thymomas and located 160 kilobase pairs downstream of Myb. |
| Q37275131 | Loss of MicroRNA targets in the 3' untranslated region as a mechanism of retroviral insertional activation of growth factor independence 1. |
| Q36688798 | Mechanism of leukemogenesis induced by mink cell focus-forming murine leukemia viruses |
| Q33810931 | Mink cell focus-forming murine leukemia virus infection induces apoptosis of thymic lymphocytes |
| Q40497129 | Modeling human retroviral pathogenesis and antiretroviral gene therapy in the SCID mouse |
| Q44439077 | Molecular analysis of the aberrant replication banding pattern on chromosome 15 in murine T-cell lymphomas |
| Q24604935 | Molecular cloning of the akt oncogene and its human homologues AKT1 and AKT2: amplification of AKT1 in a primary human gastric adenocarcinoma |
| Q37099772 | Molecular pathogenesis of feline leukemia virus-induced malignancies: insertional mutagenesis |
| Q36855137 | Mouse chromosomal mapping of a murine leukemia virus integration region (Mis-1) first identified in rat thymic leukemia |
| Q45879252 | Multiple rearrangements and activated expression of c-myc induced by woodchuck hepatitis virus integration in a primary liver tumour |
| Q53544585 | Murine T lymphomas with retroviral inserts in the chromosomal 15 locus for plasmacytoma variant translocations. |
| Q36895296 | Murine leukemia virus long terminal repeat sequences can enhance gene activity in a cell-type-specific manner |
| Q33683221 | Murine models of thymic lymphomas: premalignant scenarios amenable to prophylactic therapy. |
| Q37528796 | N-myc can cooperate with ras to transform normal cells in culture |
| Q40667918 | Neoplastic transformation of rat 3Y1 cells by a transcriptionally activated human c-myc gene and stabilization of p53 cellular tumor antigen in the transformed cells |
| Q35228687 | Non-Hodgkin's lymphomas and paraproteinaemias |
| Q35166805 | Occurrence of leukaemia following gene therapy of X-linked SCID. |
| Q33648395 | Oncogene activation in myeloid leukemias by Graffi murine leukemia virus proviral integration |
| Q39505491 | Oncogene amplification in tumor cells. |
| Q70030393 | Oncogenes and the mammalian X chromosome |
| Q40067665 | Oncogenicity of AKR mink cell focus-inducing murine leukemia virus correlates with induction of chronic phosphatidylinositol signal transduction |
| Q35787723 | Onset and dynamics of osteosclerosis in mice induced by Reilly-Finkel-Biskis (RFB) murine leukemia virus. Increase in bone mass precedes lymphomagenesis |
| Q36835881 | Presence of a c-myc transcript initiated in intron 1 in Friend erythroleukemia cells and in other murine cell types with no evidence of c-myc gene rearrangement |
| Q36617751 | Propylnitrosourea-induced T-lymphomas in LEXF RI strains of rats: genetic analysis |
| Q41403307 | Proviral activation of the putative oncogene Pim-1 in MuLV induced T-cell lymphomas |
| Q24614782 | Proviral integration site Mis-1 in rat thymomas corresponds to the pvt-1 translocation breakpoint in murine plasmacytomas |
| Q41697361 | Provirus integration at the 3' region of N-myc in cell lines established from thymic lymphomas spontaneously formed in AKR mice and a [(BALB/c x B6)F1----AKR] bone marrow chimera |
| Q39292759 | Provirus tagging as an instrument to identify oncogenes and to establish synergism between oncogenes |
| Q37635276 | Queuosine modification of tRNA: its divergent role in cellular machinery |
| Q33930366 | Radiation leukemia virus common integration at the Kis2 locus: simultaneous overexpression of a novel noncoding RNA and of the proximal Phf6 gene |
| Q41492190 | Radiation response of mouse lymphoid and myeloid cell lines. Part III. Different signals can lead to apoptosis and may influence sensitivity to killing by DNA double-strand breakage |
| Q43470081 | Rearrangement and enhanced expression of c-myc in hepatocellular carcinoma of hepatitis virus infected woodchucks |
| Q61420550 | Rearrangement and expression of T cell receptor and immunoglobulin loci in immortalized CD4−CDS−T cell lines |
| Q37399276 | Recombinant murine retroviruses containing avian v-myc induce a wide spectrum of neoplasms in newborn mice |
| Q73851246 | Release from apoptosis correlates with tumor progression in the AKR lymphoma |
| Q41752676 | Resistance of tumor-derived DNA to restriction enzyme digestion |
| Q48077600 | Retrotransposon-induced ectopic expression of the Om(2D) gene causes the eye-specific Om(2D) phenotype in Drosophila ananassae. |
| Q92731032 | Retroviral Insertional Mutagenesis in Humans: Evidence for Four Genetic Mechanisms Promoting Expansion of Cell Clones |
| Q37043126 | Retroviral Mutagenesis of Cellular Oncogenes: A Review with Insights into the Mechanisms of Insertional Activation |
| Q36353125 | Retroviral activation of interleukin 2 gene in a gibbon ape T cell lymphoma line |
| Q36681931 | Retroviral insertion mutagenesis in mice as a comparative oncogenomics tool to identify disease genes in human leukemia |
| Q36318150 | Retroviral insertional mutagenesis: past, present and future |
| Q35094507 | Retroviral insertional mutagenesis: tagging cancer pathways |
| Q37915230 | Retroviral-mediated gene transfer |
| Q39338569 | Retroviral-mediated gene transfer. Applications in neurobiology |
| Q43851664 | Retrovirus-induced lymphoproliferation as a model for developing diagnostic criteria for malignant lymphoma in mice |
| Q40106204 | SL3-3 enhancer factor 1 transcriptional activators are required for tumor formation by SL3-3 murine leukemia virus |
| Q37219609 | Safety Issues Related to Retroviral-Mediated Gene Transfer in Humans |
| Q34970423 | Selection for c-myc integration sites in polyclonal T-cell lymphomas |
| Q39874807 | Sequence tags of provirus integration sites in DNAs of tumors induced by the murine retrovirus SL3-3. |
| Q42193696 | Sequence, topography and protein coding potential of mouse int-2: a putative oncogene activated by mouse mammary tumour virus |
| Q33639086 | Sequence-specific and/or stereospecific constraints of the U3 enhancer elements of MCF 247-W are important for pathogenicity. |
| Q40136723 | Sequences outside of the long terminal repeat determine the lymphomogenic potential of Rous-associated virus type 1. |
| Q33798476 | Sint1, a common integration site in SL3-3-induced T-cell lymphomas, harbors a putative proto-oncogene with homology to the septin gene family |
| Q41687637 | Spleen focus-forming virus long terminal repeat insertional activation of the murine erythropoietin receptor gene in the T3Cl-2 friend leukemia cell line |
| Q35887850 | Stability of AML1 (core) site enhancer mutations in T lymphomas induced by attenuated SL3-3 murine leukemia virus mutants |
| Q43536279 | Suppression of leukaemia virus pathogenicity by polyoma virus enhancers |
| Q61818664 | Suppression of tumorigenicity in T-cell lymphoma hybrids is correlated with changes in myc expression and DNA replication of the myc chromosomal domain |
| Q39551832 | Suppressor mutations within the core binding factor (CBF/AML1) binding site of a T-cell lymphomagenic retrovirus. |
| Q36686229 | Susceptibility of AKXD recombinant inbred mouse strains to lymphomas. |
| Q38350567 | Svi3: A provirus common integration site in c-myc in SL/Kh pre-B lymphomas |
| Q70058394 | T-cell receptor gene rearrangement in primary tumors: effect of genetic background and inducing agent |
| Q39499404 | The Blym oncogenes |
| Q36827683 | The Mlvi-1 locus involved in the induction of rat T-cell lymphomas and the pvt-1/Mis-1 locus are identical. |
| Q72405342 | The SPT3 gene is required for normal transcription of Ty elements in S. cerevisiae |
| Q57338722 | The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice |
| Q36355008 | The endogenous mink cell focus-forming (MCF) gp70 linked to the Rmcf gene restricts MCF virus replication in vivo and provides partial resistance to erythroleukemia induced by Friend murine leukemia virus |
| Q36549315 | The feline leukemia virus long terminal repeat contains a potent genetic determinant of T-cell lymphomagenicity |
| Q37584303 | The molecular biology of radiation-induced carcinogenesis: thymic lymphoma, myeloid leukaemia and osteosarcoma |
| Q41586275 | The myc proteins are not associated with chromatin in mitotic cells. |
| Q24623127 | The path well traveled: using mammalian retroviruses to guide research on XMRV |
| Q39740844 | The pathophysiology of murine retrovirus-induced leukemias |
| Q39818292 | The role of c-myc in the proliferation of normal and neoplastic cells |
| Q35034088 | The role of non-ras transforming genes in chemical carcinogenesis |
| Q36896896 | The tandem direct repeats within the long terminal repeat of murine leukemia viruses are the primary determinant of their leukemogenic potential |
| Q36354619 | Thymic lymphoma induction by the AKT8 murine retrovirus |
| Q24645275 | Tissue selectivity of murine leukemia virus infection is determined by long terminal repeat sequences |
| Q34245556 | Tissue-specific transcription preference as a determinant of cell tropism and leukaemogenic potential of murine retroviruses |
| Q37404148 | Trans-acting elements modulate expression of the human c-myc gene in Burkitt lymphoma cells |
| Q39578843 | Transcriptional regulation of the human c-myc gene |
| Q40107937 | Transcriptionally active genome regions are preferred targets for retrovirus integration. |
| Q40463180 | Trasiocation affects normalc-mycpromoter usage and activates fifteen crypticc-myctranscription starts in plasmacytoma M603 |
| Q41349782 | Truncation does not abrogate transcriptional downregulation of the c-myc gene by sodium butyrate in Burkitt's lymphoma cells |
| Q40131234 | Tumor progression in murine leukemia virus-induced T-cell lymphomas: monitoring clonal selections with viral and cellular probes |
| Q41669645 | Tumorigenesis of a v-Ha-ras-expressing pre-B cell line selects for c-myc activation |
| Q24555810 | Variant (6;15) translocations in murine plasmacytomas involve a chromosome 15 locus at least 72 kb from the c-myc oncogene |
| Q37576088 | Viral integration near c-myc in 10-20% of mcf 247-induced AKR lymphomas |
| Q34662891 | What retroviruses teach us about the involvement of c-Myc in leukemias and lymphomas |
| Q24317747 | cDNA sequence and genomic structure of EV12B, a gene lying within an intron of the neurofibromatosis type 1 gene |
| Q33928986 | fim-1 and fim-2: two new integration regions of Friend murine leukemia virus in myeloblastic leukemias |
| Q36810891 | flvi-1, a common integration domain of feline leukemia virus in naturally occurring lymphomas of a particular type |
| Q37511853 | myc family oncogenes in the development of normal and neoplastic cells. |
Search more.